Hims & Hers Health announced the launch of a new specialty in women’s health, offering access to treatment plans for women experiencing perimenopause and menopause. Starting today, women can work with a provider on the platform to access tailored treatment plans. Hims & Hers Health’s women’s health division serves over half a million subscribers and is on track to surpass $1B of annual revenue in 2026.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Option traders moderately bearish in Hims and Hers Health with shares down 1.29%
- Mixed options sentiment in Hims and Hers Health with shares up 1.3%
- Option traders moderately bearish in Hims and Hers Health with shares down 5.36%
- BofA lowers Q4 sales estimates for Hims & Hers
- Roundhill Launches Meme Stock ETF as CEO Says ‘Retail Investors’ Are a ‘Permanent Force’